• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Hercules Capital Reports First Quarter 2025 Financial Results

    5/1/25 4:04:00 PM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance
    Get the next $HCXY alert in real time by email

    Q1 2025 Total Gross Debt and Equity Commitments of $1.02 Billion

    Q1 2025 Total Gross Fundings of $539.1 Million

    Q1 2025 Total Investment Income of $119.5 Million

    Q1 2025 Net Investment Income "NII" of $77.5 Million, or $0.45 per Share

    Q1 2025 NII of $0.45 per Share, provides 113% Coverage of the Base Cash Distribution

    Received an Investment Grade Rating Upgrade to BBB (high) from Morningstar DBRS

    Closed Offering of $287.5 Million of 4.750% Convertible Unsecured Notes due 2028

    Conservative Balance Sheet Management with Net GAAP Leverage of 97.4% and Net Regulatory Leverage of 82.7%(1)

    Inclusive of the Adviser Funds Advised by Hercules Adviser LLC, its Wholly-Owned Subsidiary, Hercules had over $1.0 Billion of Available Liquidity as of the end of Q1 2025

    Undistributed Earnings Spillover of $159.6 Million, or $0.92(2) per Ending Shares Outstanding

    Over $5.0 Billion of Assets Under Management, an Increase of 11.0% Year-over-Year(3)

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31, 2025. The earnings release can be accessed at Hercules' Investor Relations website at https://investor.htgc.com/financial-information/financial-results.

    Footnotes:

    (1) Included in the earnings release is a reconciliation of any non-GAAP measures included therein

    (2) $0.93 per Weighted Average Shares Outstanding

    (3) Assets under management includes assets managed by Hercules and the Adviser Subsidiary

    Conference Call

    Hercules has scheduled its first quarter 2025 financial results conference call for May 1, 2025 at 2:00 p.m. PT (5:00 p.m. ET). To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. While not required, it is recommended you join 10 minutes prior to the event start. A live webcast of the first quarter 2025 financial results conference call will also be available on the investor relations section of the Company's website at investor.htgc.com. An archived webcast replay will be available on the Company's website for at least 30 days following the conference call.

    About Hercules Capital, Inc.

    Hercules Capital, Inc. (NYSE:HTGC) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology and life sciences industries. Since inception (December 2003), Hercules has committed more than $22 billion to over 680 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. Companies interested in learning more about financing opportunities should contact [email protected], or call 650.289.3060.

    Hercules, through its wholly owned subsidiary business, Hercules Adviser LLC (the "Adviser Subsidiary"), also maintains an asset management business through which it manages investments for external parties ("Adviser Funds"). The Adviser Subsidiary is registered as an investment adviser under the Investment Advisers Act of 1940.

    Hercules' common stock trades on the New York Stock Exchange (NYSE) under the ticker symbol "HTGC." In addition, Hercules has one retail bond issuance of 6.25% Notes due 2033 (NYSE:HCXY).

    Forward-Looking Statements

    This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. We may use words such as "anticipates," "believes," "expects," "intends," "will," "should," "may" and similar expressions to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and should not be relied upon in making any investment decision. Such statements are based on currently available operating, financial and competitive information and are subject to various risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations. While we cannot identify all such risks and uncertainties, we urge you to read the risks discussed in our Annual Report on Form 10-K and other materials that we publicly file with the Securities and Exchange Commission. Any forward-looking statements made in this press release are made only as of the date hereof. Hercules assumes no obligation to update any such statements in the future.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250501258025/en/

    Michael Hara

    Investor Relations and Corporate Communications

    Hercules Capital, Inc.

    650-433-5578

    [email protected]

    Get the next $HCXY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HCXY
    $HTGC

    CompanyDatePrice TargetRatingAnalyst
    Hercules Capital Inc.
    $HTGC
    12/12/2024$19.50 → $21.50Mkt Perform → Outperform
    Keefe Bruyette
    Hercules Capital Inc.
    $HTGC
    1/16/2024$17.00 → $17.50Buy → Neutral
    Compass Point
    Hercules Capital Inc.
    $HTGC
    11/21/2023$17.00Neutral
    UBS
    Hercules Capital Inc.
    $HTGC
    8/30/2023$17.50Neutral → Buy
    Compass Point
    Hercules Capital Inc.
    $HTGC
    8/4/2023$13.50 → $17.00Underperform → Mkt Perform
    Keefe Bruyette
    Hercules Capital Inc.
    $HTGC
    4/6/2023$16.00Neutral → Overweight
    Piper Sandler
    Hercules Capital Inc.
    $HTGC
    3/13/2023$14.50 → $10.50Mkt Perform → Underperform
    Keefe Bruyette
    Hercules Capital Inc.
    $HTGC
    7/29/2022Outperform → Perform
    Oppenheimer
    More analyst ratings